help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brawer, J. R.
Right arrow Articles by Naftolin, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brawer, J. R.
Right arrow Articles by Naftolin, F.

Endocrinology, Vol 107, 274-279, Copyright © 1980 by Endocrine Society


ARTICLES

Ovary-dependent degeneration in the hypothalamic arcuate nucleus

JR Brawer, H Schipper and F Naftolin

The effects of estradiol valerate and constant light exposure on the histological appearance of the arcuate nucleus were assessed in female rats. Both of these treatments caused significant increases in the numbers of reactive microglial cells and astrocytic granules in the nucleus. Ovariectomy before either treatment prevented the glial reaction, indicating that the experimental manipulations triggered the secretion of an ovarian product which appears to be selectively toxic to the arcuate nucleus. The fact that monthly injections of estradiol valerate in male rats produced the same profile of degeneration in the arcuate nucleus suggests that the neuropathological agent may itself be estradiol. Ovariectomy also significantly reduced arcuate microglial reactivity associated with normal aging, which suggests that cyclic surges of endogenous estradiol may be capable of gradually producing an arcuate lesion. This phenomenon may accout for the hypothalamic reproductive failure associated with normal aging in the rat.


This article has been cited by other articles:


Home page
Toxicol SciHome page
R. L. Cooper, T. E. Stoker, L. Tyrey, J. M. Goldman, and W. K. McElroy
Atrazine Disrupts the Hypothalamic Control of Pituitary-Ovarian Function
Toxicol. Sci., February 1, 2000; 53(2): 297 - 307.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. W. Abel, M. L. Voytko, and N. E. Rance
The Effects of Hormone Replacement Therapy on Hypothalamic Neuropeptide Gene Expression in a Primate Model of Menopause
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2111 - 2118.
[Abstract] [Full Text]


Home page
ScienceHome page
P. Landfield, R. Baskin, and T. Pitler
Brain aging correlates: retardation by hormonal-pharmacological treatments
Science, October 30, 1981; 214(4520): 581 - 584.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society